The underpinnings of cancer metastasis remain poorly understood, in part due to a lack of tools for probing their emergence at high resolution. Here we present macsGESTALT, an inducible CRISPR-Cas9-based lineage recorder with highly efficient single-cell capture of both transcriptional and phylogenetic information. Applying macsGESTALT to a mouse model of metastatic pancreatic cancer, we recover ~380,000 CRISPR target sites and reconstruct dissemination of ~28,000 single cells across multiple metastatic sites. We find cells occupy a continuum of epithelial-to-mesenchymal transition (EMT) states. Metastatic potential peaks in rare, late-hybrid EMT states, which are aggressively selected from a predominately epithelial ancestral pool. The gen...
Tumor evolution is driven by the progressive acquisition of genetic and epigenetic alterations that ...
Tumor evolution is driven by the progressive acquisition of genetic and epigenetic alterations that ...
Breast cancer (BC) represents a major clinical hurdle, with metastatic outcome accounting for poor p...
The underpinnings of cancer metastasis remain poorly understood, in part due to a lack of tools for ...
Cellular lineages underlie several important biological phenomena, from embyrogenesis to tumor devel...
Detailed phylogenies of tumor populations can recount the history and chronology of critical events ...
The primary cause of cancer-related deaths is metastasis— the spread of cancer cells to distant orga...
Metastasis is the primary cause of human cancer deaths. Patients with metastatic colorectal cancer (...
Metastatic lung cancer has a 5-year survival rate of 5%. Lung cancers tend to be asymptomatic until ...
Genetic screens are powerful tools for identifying genes responsible for diverse phenotypes. Here we...
SummaryGenetic screens are powerful tools for identifying genes responsible for diverse phenotypes. ...
Nine out of every ten cancer-related deaths is caused by metastasis, but the molecular mechanisms dr...
In recent years, technological advancements, such as next-generation sequencing and single-cell inte...
The primary cause of cancer-related deaths is metastasis— the spread of cancer cells to distant orga...
© 2019 The Royal Society of Chemistry.Considerable evidence suggests breast cancer metastasis arises...
Tumor evolution is driven by the progressive acquisition of genetic and epigenetic alterations that ...
Tumor evolution is driven by the progressive acquisition of genetic and epigenetic alterations that ...
Breast cancer (BC) represents a major clinical hurdle, with metastatic outcome accounting for poor p...
The underpinnings of cancer metastasis remain poorly understood, in part due to a lack of tools for ...
Cellular lineages underlie several important biological phenomena, from embyrogenesis to tumor devel...
Detailed phylogenies of tumor populations can recount the history and chronology of critical events ...
The primary cause of cancer-related deaths is metastasis— the spread of cancer cells to distant orga...
Metastasis is the primary cause of human cancer deaths. Patients with metastatic colorectal cancer (...
Metastatic lung cancer has a 5-year survival rate of 5%. Lung cancers tend to be asymptomatic until ...
Genetic screens are powerful tools for identifying genes responsible for diverse phenotypes. Here we...
SummaryGenetic screens are powerful tools for identifying genes responsible for diverse phenotypes. ...
Nine out of every ten cancer-related deaths is caused by metastasis, but the molecular mechanisms dr...
In recent years, technological advancements, such as next-generation sequencing and single-cell inte...
The primary cause of cancer-related deaths is metastasis— the spread of cancer cells to distant orga...
© 2019 The Royal Society of Chemistry.Considerable evidence suggests breast cancer metastasis arises...
Tumor evolution is driven by the progressive acquisition of genetic and epigenetic alterations that ...
Tumor evolution is driven by the progressive acquisition of genetic and epigenetic alterations that ...
Breast cancer (BC) represents a major clinical hurdle, with metastatic outcome accounting for poor p...